Six serious injuries and one death

Six serious injuries and one deathTeGenero, a development stage pharmaceutical company you never heard of before their drug trial almost killed six healthy volunteers, has declared bankruptcy.

The unforeseeable adverse reactions caused by TGN1412 in the TGN1412-HV phase 1 trial have made it impossible to attract the investment necessary for the company to continue operations.